Search Results - F. Lordick

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    ESMO Gastrointestinal Oncology – Expedition into a new era of research and better care by I. Ben-Aharon, F. Lordick

    Published in ESMO Gastrointestinal Oncology (2023-10-01)
    Get full text
    Article


  2. 2

    Immune checkpoint inhibition (ICI) in current systemic therapies for hepatocellular carcinoma (HCC) by F. van Bömmel, T. Berg, F. Lordick

    Published in ESMO Gastrointestinal Oncology (2023-10-01)
    Get full text
    Article


  3. 3

    ESMO pays tribute to Professor José Baselga by S. Peters, J. Tabernero, A. Cervantes, S. Banerjee, R. Giuliani, F. Lordick

    Published in Immuno-Oncology and Technology (2021-03-01)
    Get full text
    Article


  4. 4

    SAGA—a phase Ib/II single-arm, multicenter study of sacituzumab govitecan for patients with metastatic esophagogastric adenocarcinoma by B. Kobitzsch, G. Stocker, U.T. Hacker, S. Junge, C. Pauligk, S.-E. Al-Batran, T.O. Goetze, F. Lordick

    Published in ESMO Gastrointestinal Oncology (2024-06-01)
    Get full text
    Article


  5. 5

    Exploring the pathway: clinical utility and open challenges of targeting BRAF alterations in biliary tract cancers and gastrointestinal malignancies by L. Weiss, D. Zhang, W.G. Kunz, S. Boeck, G. Curigliano, V. Subbiah, F. Lordick, T. Brummer, C.B. Westphalen, L. Boscolo Bielo

    Published in ESMO Gastrointestinal Oncology (2025-03-01)
    Get full text
    Article


  6. 6

    Hepatic chemosaturation with melphalan in patients with primary or secondary liver tumors with or without extrahepatic tumor manifestation by R. Veelken, S. Ebel, A. Schindler, F. Lordick, M.F. Struck, C. Girbardt, F. Ziemssen, D. Seehofer, T. Denecke, T. Berg, F. van Bömmel

    Published in ESMO Gastrointestinal Oncology (2024-09-01)
    Get full text
    Article


  7. 7

    SAPHIR: real-world clinical research platform for molecular testing, treatment, and clinical and patient-reported outcomes in patients with gastroesophageal cancer in Germany by K. Potthoff, T. Dechow, S. Lorenzen, A. Reinacher-Schick, A. Binninger, C. Matillon, H.-U. Siebenbach, I. Haffner, U. Hacker, H. Bläker, F. Lordick

    Published in ESMO Real World Data and Digital Oncology (2023-12-01)
    Get full text
    Article


  8. 8

    HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2) IN GASTRIC CANCER (GC) (RESULTS OF THE MULTICENTER CLINICAL TRIAL) by H. C. Chung, Y-J. Bang, J. M. Xu, F. Lordick, A. Sawaki, O. Lipatov, M. Lehle, М. Pickl, J. Ruschoff, E. Van Cutsem

    Get full text
    Article


  9. 9

    Sex differences in the incidence trends of early-onset gastrointestinal cancer—the European/Mediterranean perspective by I. Ben-Aharon, N. Fokter Dovnik, H.W.M. van Laarhoven, M.G. Guren, I. Baraibar, N. Gordon, T. Goshen-Lago, R. Verhoeven, T. Sokop, R. Obermannova, F. Lordick

    Published in ESMO Gastrointestinal Oncology (2025-12-01)
    Get full text
    Article


  10. 10

    Impact of nutritional risk screening on outcomes of first-line treatment in metastatic esophagogastric adenocarcinoma: a secondary analysis of the AIO-MATEO trial by R. Stelmach, S. Lorenzen, T.J. Ettrich, F.R. Longo, B. Chibaudel, R. Greil, M. Perwög, J. Larcher-Steiner, D. Jäger, F. Lordick, G. Stocker, G.M. Haag

    Published in ESMO Gastrointestinal Oncology (2026-03-01)
    Get full text
    Article


  11. 11

    Current practices and challenges in implementing precision medicine for upper gastrointestinal cancers in European academic centers: an EORTC survey by M. Alsina, A.E. Huerta, F. Lordick, S. Verschueren, M. Moehler, E. Fontana, E. Smyth, F. Sclafani, A.D. Wagner, L. Rimassa, A. Lamarca, C. Neuzillet, R. Obermannová

    Published in ESMO Gastrointestinal Oncology (2024-09-01)
    Get full text
    Article


  12. 12

    Role of the microbiome in the development and treatment of gastric cancer: an overview of the biological and clinical landscape by C.A. Cella, D. Ciardiello, L. Gervaso, H. van Laarhoven, L. Nezi, C. Catozzi, F. Lordick, E. Smyth, S. de Pascale, L. Benini, C. Valenza, L. Guidi, U. Fumagalli Romario, N. Fazio

    Published in ESMO Gastrointestinal Oncology (2024-06-01)
    Get full text
    Article


  13. 13

    European screening platform for EORTC clinical trials in advanced colorectal cancer ‘SPECTAcolor’ by G. Folprecht, M. Morfouace, M. Collienne, R. Salazar, A. Stein, E. Elez, A.D. Wagner, D. Arnold, C.H. Kohne, M. Ducreux, F. Lordick, B. Borelli, A. Stevovic, T. Gorlia, E. Fontana, D. Aust, V. Golfinopoulos, M. Moehler, S. Tejpar

    Published in ESMO Gastrointestinal Oncology (2025-06-01)
    Get full text
    Article


  14. 14

    Local and central testing for HER2, PD-L1, MSI/MMR, EBV, and CLDN18.2 in advanced gastric cancer: results from the SAPHIR registry☆ by K. Potthoff, H. Bläker, T. Dechow, A. Binninger, K. Ringwald, R. de Buhr, E. von der Heyde, M.-O. Zahn, A. Nusch, S. Dörfel, H. Schulz, I. Haffner, A.K. Höhn, A. Monecke, S. Lorenzen, A. Reinacher-Schick, M. Jänicke, F. Lordick

    Published in ESMO Real World Data and Digital Oncology (2025-06-01)
    Get full text
    Article


  15. 15

    German guidelines for the diagnosis and treatment of squamous-cell carcinoma and adenocarcinoma of the esophagus—version 4.0 by M.P. Ebert, W. Fischbach, S. Hollerbach, J. Höppner, D. Lorenz, M. Stahl, M. Stuschke, O. Pech, U. Vanhoefer, C. Bruns, C. Ell, M. Follmann, U. Goerling, L. Grenacher, J. Haardt, A.H. Hölscher, R. Hummel, W.T. Knoefel, J. Körber, R. Langer, P. Lenz, F. Lordick, S. Lorenzen, A.G. Meining, J. Menzel, H.-J. Meyer, N.H. Nicolay, M. Nothacker, U. Nöthlings, H. Schmidberger, M. Schmidt, T. Seufferlein, P. Thuss-Patience, J. Trojan, A. Weimann, L. Klug, P. Lynen, T. Zhan, Q. Xiao, R. Porschen

    Published in ESMO Gastrointestinal Oncology (2025-03-01)
    Get full text
    Article


Search Tools: